| Fund ID | 805-1895833849 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 34% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 93% |
| Fund | Type | Gross assets |
|---|---|---|
| Sagard Healthcare Royalty Partners LP | Private Equity | $353.6M |
| Sagard Healthcare Partners (892) Holdings, LP | Private Equity | $320.2M |
| Portage Capital Solutions Fund I LP | Private Equity | $237M |
Portag3 Ventures II International LP reports $87 million in gross assets, among the top 45% of private funds by size.
The stated minimum investment is $15 million.
Portag3 Ventures II International LP is managed by Sagard Holdings Manager LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.